Free Trial

Chemours (CC) Competitors

Chemours logo
$13.81 -0.24 (-1.71%)
Closing price 07/11/2025 03:59 PM Eastern
Extended Trading
$13.80 -0.01 (-0.04%)
As of 07/11/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CC vs. ASIX, CE, DD, DOW, EMN, HUN, NTR, OLN, TROX, and AXTA

Should you be buying Chemours stock or one of its competitors? The main competitors of Chemours include AdvanSix (ASIX), Celanese (CE), DuPont de Nemours (DD), DOW (DOW), Eastman Chemical (EMN), Huntsman (HUN), Nutrien (NTR), Olin (OLN), Tronox (TROX), and Axalta Coating Systems (AXTA). These companies are all part of the "basic materials" sector.

Chemours vs. Its Competitors

Chemours (NYSE:CC) and AdvanSix (NYSE:ASIX) are both basic materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, media sentiment, valuation and risk.

Chemours has a beta of 1.65, suggesting that its share price is 65% more volatile than the S&P 500. Comparatively, AdvanSix has a beta of 1.6, suggesting that its share price is 60% more volatile than the S&P 500.

76.3% of Chemours shares are owned by institutional investors. Comparatively, 86.4% of AdvanSix shares are owned by institutional investors. 0.5% of Chemours shares are owned by company insiders. Comparatively, 5.6% of AdvanSix shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Chemours presently has a consensus target price of $17.33, indicating a potential upside of 25.51%. AdvanSix has a consensus target price of $33.50, indicating a potential upside of 45.27%. Given AdvanSix's stronger consensus rating and higher probable upside, analysts plainly believe AdvanSix is more favorable than Chemours.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Chemours
0 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.56
AdvanSix
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.5%. AdvanSix pays an annual dividend of $0.64 per share and has a dividend yield of 2.8%. Chemours pays out 175.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. AdvanSix pays out 20.5% of its earnings in the form of a dividend. AdvanSix has increased its dividend for 2 consecutive years. AdvanSix is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Chemours had 12 more articles in the media than AdvanSix. MarketBeat recorded 18 mentions for Chemours and 6 mentions for AdvanSix. Chemours' average media sentiment score of 0.46 beat AdvanSix's score of 0.05 indicating that Chemours is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Chemours
7 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
AdvanSix
0 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

AdvanSix has a net margin of 5.45% compared to Chemours' net margin of 0.54%. Chemours' return on equity of 23.82% beat AdvanSix's return on equity.

Company Net Margins Return on Equity Return on Assets
Chemours0.54% 23.82% 2.07%
AdvanSix 5.45%11.38%5.65%

Chemours has higher revenue and earnings than AdvanSix. AdvanSix is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chemours$5.78B0.36$86M$0.2069.05
AdvanSix$1.52B0.41$44.15M$3.127.39

Summary

AdvanSix beats Chemours on 11 of the 19 factors compared between the two stocks.

Get Chemours News Delivered to You Automatically

Sign up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CC vs. The Competition

MetricChemoursCHEM IndustryMaterials SectorNYSE Exchange
Market Cap$2.10B$11.93B$3.31B$20.79B
Dividend Yield2.49%3.29%5.14%3.71%
P/E Ratio69.0522.9192.7527.89
Price / Sales0.364.7731,218,733,196,606,700.0042.50
Price / Cash3.817.7423.8722.63
Price / Book3.411.646.074.57
Net Income$86M$507.43M$147.90M$988.81M
7 Day Performance8.53%2.82%2.29%0.20%
1 Month Performance20.40%5.65%6.56%3.93%
1 Year Performance-43.63%-4.92%26.87%10.27%

Chemours Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CC
Chemours
4.4536 of 5 stars
$13.81
-1.7%
$17.33
+25.5%
-43.1%$2.10B$5.78B69.056,000News Coverage
Analyst Revision
ASIX
AdvanSix
3.7872 of 5 stars
$23.79
-1.5%
$33.50
+40.8%
-0.3%$637.81M$1.52B7.631,450News Coverage
CE
Celanese
3.7067 of 5 stars
$55.48
-2.3%
$63.11
+13.8%
-56.2%$6.07B$10.28B-3.6512,163Positive News
Analyst Forecast
DD
DuPont de Nemours
4.6526 of 5 stars
$68.57
-0.5%
$85.92
+25.3%
-6.5%$28.70B$12.39B-360.8923,000Positive News
Analyst Forecast
DOW
DOW
3.299 of 5 stars
$26.53
-1.7%
$36.57
+37.8%
-43.6%$18.75B$42.96B66.3336,000Analyst Forecast
Gap Down
EMN
Eastman Chemical
4.7869 of 5 stars
$74.75
-1.9%
$98.54
+31.8%
-18.3%$8.63B$9.38B9.5114,000Positive News
Analyst Forecast
High Trading Volume
HUN
Huntsman
4.0897 of 5 stars
$10.42
-1.3%
$15.00
+44.0%
-49.1%$1.81B$6.04B-11.456,300News Coverage
Analyst Forecast
Gap Down
NTR
Nutrien
3.3741 of 5 stars
$58.19
+0.1%
$62.12
+6.7%
+22.7%$28.34B$25.97B54.3824,700Positive News
Analyst Forecast
OLN
Olin
4.6187 of 5 stars
$20.07
-1.8%
$27.80
+38.5%
-54.0%$2.31B$6.54B39.357,676Analyst Forecast
Options Volume
TROX
Tronox
4.6788 of 5 stars
$5.07
-10.1%
$7.63
+50.4%
-65.6%$803.39M$3.07B-5.346,500Analyst Forecast
Gap Down
High Trading Volume
AXTA
Axalta Coating Systems
4.9204 of 5 stars
$29.71
-0.5%
$40.50
+36.3%
-14.0%$6.49B$5.28B14.4912,800

Related Companies and Tools


This page (NYSE:CC) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners